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In 1978, I wrote a letter to Ben Lewin, then editor of 
Cell, asking him to consider two manuscripts on the 
biochemical properties of the infectious particle causing 
experimental scrapie in mice. We had learned that the 
infectious scrapie particles could acquire a wide variety 
of sizes and that this behavior could not be altered 
by detergents or salts under conditions that preserved 
infectivity. We concluded that this non-ideal behavior 
was the result of hydrophobic interactions (Prusiner et 
al., 1978a, 1978b). The experiments had taken nearly 
four years to perform. Indeed, the work was heroic, but 
I knew that it was correct because we had repeated the 
work at least once and often twice so that I was confident 
of the results. 
Needless to say, I was sad when Ben Lewin responded 
with a recommendation that we send him a paper once 
we had purified the scrapie agent. It was as if he ignored 
the challenges that our findings presented. At that time, 
it was clear that the physical properties of the scrapie 
agent were sufficiently non-ideal as to herald a biochem- 
ical nightmare. We were to struggle for the next four 
years before we discovered the protein of the scrapie 
agent in 1982. By that time, it seemed highly likely that 
the infectious particle causing scrapie was not a slow 
acting virus, which was the favored hypothesis. To dis- 
tinguish the scrapie agent from viruses, I suggested that 
the term "prion" might be more appropriate in describing 
these novel proteinaceous infectious particles (Prusi- 
ner, 1982). 
The discovery of the prion protein (PrP) occurred only 
after we developed an incubation-time assay that accel- 
erated almost 100-fold our efforts directed toward purifi- 
cation of the scrapie agent (Bolton et al., 1982; Prusiner 
et al., 1980, 1982). Once we were able to produce the 
purified protein PrP 27-30 in large quantities (Prusiner 
et al., 1983), we were in a position to probe more exten- 
sively the issue of whether or not PrP 27-30 was an 
essential component of the infectious particle. After ra- 
diolabeling purified fractions with 1251, we found that one 
protein, PrP 27-30, was the predominant iodinated mol- 
ecule. 
With r2~l]-PrP 27-30 available, we decided to investi- 
gate the kinetics of PrP 27-30 and the degradation of 
infectivity (McKinley et al., 1983). We wanted to know 
whether degradation of the protein and infectivity were 
coincident or divergent. As described in the article by 
McKinley et al., we were unable to separate PrP 27-30 
from prion infectivity. The kinetics of PrP 27-30 proteoly- 
sis catalyzed by proteinase K were indistinguishable 
from the diminution of prion infectivity as determined 
by incubation-time bioassays performed in Syrian ham- 
sters. Although PrP 27-30 and infectivity were stable for 
2 hr in the presence of proteinase K, longer digestions 
diminished both the protein and the prion titer. Pro- 
longed digestion with either trypsin or SV-8 had no effect 
on PrP 27-30 or infectivity. 
We concluded that the results of these studies pro- 
vided evidence in support of our postulate that PrP 27- 
30 is an essential and, perhaps, the sole, component of 
the infectious prion particle. Now we had what I thought 
was likely to be a Cell paper. After hastily preparing the 
manuscript, we sent it to Cell and were delighted when 
Ben Lewin accepted the paper with, of course, some 
revisions. Another decade was to pass before enough 
data would be gathered using many independent disci- 
plines to build compelling evidence on the composition 
of prions (Prusiner, 1991, 1998). 
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